Albendazole therapy for single small enhancing CT lesions (SSECTL) in the brain in epilepsy
Affiliations
Affiliations
- Neurology Unit, Department of Medicine, Amiri Hospital, Ministry of Health, Kuwait. a_thussu@hotmail.com
Abstract
Background: Single small enhancing CT lesions (SSECTL) of the brain with or without perifocal oedema are common in patients with symptomatic epilepsy in India. Solitary cysticercus granuloma, a benign form of parenchymal neurocysticercosis, is considered to be the most common aetiology for SSECTL. Definite information is lacking regarding the effectiveness of antiparasitic treatment on resolution of these lesions and on long term seizure recurrence.
Objective: To evaluate the response to albendazole treatment in patients who had SSECTL and new onset seizures treated with antiepileptic drugs (AED) in a prospective clinical trial.
Methods: 43 patients who presented with new onset seizures and were documented to have SSECTL were alternatively allocated to receive albendazole 15 mg/kg/day for 2 weeks or no cysticidal therapy. All patients were treated with AED and followed for at least 6 months for seizure recurrence, and serial CT scans were obtained at 4 weeks, 3 months and at study completion.
Results: 28 (65%) patients were aged 5-25 years and 31 (72%) presented clinically with partial motor seizures with or without generalisation. Most of the SSECTL were ring lesions (75%) and located in and around the sensory-motor cortex at the gray-white junction (65%). In the albendazole group, 56% of patients compared with 35% in the control group showed resolution of SSECTL (p = 0.154) at 1 month. 22 of 23 patients (95.6%), who received albendazole, compared with 14 of 20 patients (70%) in the control group, demonstrated radiological resolution on study completion (p = 0.03). Punctate residual calcification and seizure recurrence were observed in four patients (9.3%) in the control group and in three (7%) patients in the albendazole group (p = 0.47).
Conclusions: In patients presenting with seizures due to single viable parenchymal neurocysticercosis, albendazole hastens the resolution of SSECTL if treatment is given in the early phase of the illness.
Similar articles
Kalra V, Dua T, Kumar V.J Pediatr. 2003 Jul;143(1):111-4. doi: 10.1016/S0022-3476(03)00211-7.PMID: 12915835 Clinical Trial.
Baranwal AK, Singhi PD, Khandelwal N, Singhi SC.Pediatr Infect Dis J. 1998 Aug;17(8):696-700. doi: 10.1097/00006454-199808000-00007.PMID: 9726343 Clinical Trial.
Singhi P, Jain V, Khandelwal N.J Child Neurol. 2004 May;19(5):323-7. doi: 10.1177/088307380401900503.PMID: 15224704 Clinical Trial.
Singhi PD, Baranwal AK.J Trop Pediatr. 2001 Oct;47(5):266-70. doi: 10.1093/tropej/47.5.266.PMID: 11695724 Review.
Controversies in the treatment of seizures associated with neurocysticercosis.
Singh G, Sharma R.Epilepsy Behav. 2017 Nov;76:163-167. doi: 10.1016/j.yebeh.2017.05.033. Epub 2017 Jun 30.PMID: 28673685 Review.
Cited by
CystiHuman: A model of human neurocysticercosis.
Bonnet G, Pizzitutti F, Gonzales-Gustavson EA, Gabriƫl S, Pan WK, Garcia HH, Bustos JA, Vilchez P, O'Neal SE; Cysticercosis Working Group in Peru.PLoS Comput Biol. 2022 May 19;18(5):e1010118. doi: 10.1371/journal.pcbi.1010118. eCollection 2022 May.PMID: 35587497 Free PMC article.
Anthelmintics for people with neurocysticercosis.
Monk EJM, Abba K, Ranganathan LN.Cochrane Database Syst Rev. 2021 Jun 1;6(6):CD000215. doi: 10.1002/14651858.CD000215.pub5.PMID: 34060667 Free PMC article.
Frequency and Determinant Factors for Calcification in Neurocysticercosis.
Bustos JA, Arroyo G, Gilman RH, Soto-Becerra P, Gonzales I, Saavedra H, Pretell EJ, Nash TE, O'Neal SE, Del Brutto OH, Gonzalez AE, Garcia HH; Cysticercosis Working Group in Peru.Clin Infect Dis. 2021 Nov 2;73(9):e2592-e2600. doi: 10.1093/cid/ciaa784.PMID: 32556276 Free PMC article.
Clinical topography relationship in patients with parenchymal neurocysticercosis and seizures.
Duque KR, Escalaya AL, Zapata W, Burneo JG, Bustos JA, Gonzales I, Saavedra H, Pretell EJ, Garcia HH; Cysticercosis Working Group in Peru.Epilepsy Res. 2018 Sep;145:145-152. doi: 10.1016/j.eplepsyres.2018.06.011. Epub 2018 Jun 28.PMID: 30007239 Free PMC article.
White AC Jr, Coyle CM, Rajshekhar V, Singh G, Hauser WA, Mohanty A, Garcia HH, Nash TE.Am J Trop Med Hyg. 2018 Apr;98(4):945-966. doi: 10.4269/ajtmh.18-88751.PMID: 29644966 Free PMC article. No abstract available.